Together with our network, we’re building a connected mental health data landscape that drives better research, innovation, and real-world impact.

DATAMIND works with a range of partners who share our goal of improving mental health through better use of data. Funded by the Medical Research Council (MRC), we support collaboration across research, policy, and practice. Our partners include national programmes focused on suicide and self-harm prevention, reducing mental health inequalities, and strengthening population mental health — all helping to turn data into real-world impact.

Mental Health Platform

DATAMIND is the mental health data science hub of the Mental Health Platform, a Medical Research Council (MRC) initiative on behalf of UK Research and Innovation (UKRI). The platform consists of five challenge-led research hubs focused on collaboration, data sharing, and engagement with the NHS, academia, industry, and the public to accelerate research into severe mental illnesses and develop more effective treatments. DATAMIND provides the data infrastructure needed to support these hubs. The five other hubs of the Mental Health Platform will be able to access existing data from DATAMIND and contribute their own as it is generated. The platform will bring together, curate, and make important new information available to the wider research community.

Mental Health Mission

DATAMIND is partnered with the Mental Health Mission, which aims to address the urgent need for new treatment options for people with mental health conditions and to position the UK as a leader in mental health research innovation. DATAMIND will support the mission by providing robust data and digital infrastructure. This includes utilising routinely collected data, introducing new types of data for measurement, recruitment, outcomes, and enhancing trial platforms with informatics.

PHI-UK’s Population Mental Health

DATAMIND is partnered with PHI-UK’s Population Mental Health Consortium (PMHC), a UKRI-funded initiative dedicated to tackling health inequalities and improving population mental health through prevention. Their work includes building coalitions to drive innovation in research methods, leveraging data to evaluate public health policies, addressing intersectional inequalities, and developing training programmes for stakeholders. PMHC focuses on suicide and self-harm prevention, reducing mental health inequalities among individuals with multiple long-term conditions, and providing tailored interventions to support children and young people.

National Centre for Suicide Prevention and Self-Harm

DATAMIND is partnered with the National Centre for Suicide Prevention and Self-Harm, which aims to advance research, inform policy, and develop evidence-based interventions to reduce suicide and self-harm in Wales. The Centre brings together researchers, policymakers, healthcare professionals, and people with lived experience to drive meaningful change and improve support for those at risk.

Understanding Mental Health Data

Despite the health, social and economic burden caused by mental health problems, research is constrained by lack of public trust and engagement. This lack of trust is exacerbated by experiences of social exclusion and/or coercive treatment. While previous research demonstrates support for sharing de-identified NHS data to NHS, academic and charity researchers, this is not the case for Industry. DATAMIND aims to address this by co-developing global standards for the use of mental health data by Industry. However, before bringing Industry, the Public and Patients together, we must facilitate conversations about data research while considering ethical issues. In this project funded by Higher Education Funding Council for Wales via Swansea University Research Wales Innovation Fund, DATAMIND will co-produce together with the McPin Foundation a data literacy course providing clarity and understanding on the use of data for research by all, including Industry.

Landscaping International Longitudinal Datasets

Louise Arseneault (FAIR Curated Mental Health Data Lead), Elena Triantafillopoulou (FAIR Curated Mental Health Data Project Manager), and the rest of their team based at King’s College London are working on the Landscaping International Longitudinal Datasets project, funded by the Wellcome Trust and in partnership with MQ Mental Health Research, the Open Data Institute, the Centre for Global Mental Health, Wellcome Lived Experience Expert Advisors, and DATAMIND. The aim of this project is to identify longitudinal datasets from across the world that can be best used to advance our understanding how brain, body and environment interact in the trajectory of anxiety, depression and psychosis. Through the project, the team has been increasing the discoverability of international longitudinal datasets worldwide.

Establishing the Eating Disorders Clinical Research Network (EDCRN)

The EDCRN aims to create a step change in the ability of researchers to perform innovative research, both in terms of simulated clinical trials and to perform biomarker studies. The extensive biorepository of samples would help to push forward research on biomarkers for eating disorders. DATAMIND will provide advice and collaborate with EDCRN on enabling and planning data linkage and its hosting on a secure trusted research environment.

Clinical Records Anonymisation and Text Extraction (CRATE)

This free open-source software enables organizations, such as NHS Trusts, to de-identify electronic health records for research, in a suitably secure environment and with appropriate ethical and information governance controls in place. The software support extraction of text (including from binary documents); person-specific and generic de-identification methods and anonymisation/pseudonymisation; techniques for de-identified linkage; natural language processing systems (to extract structured data from unstructured text); research interfaces, such as for epidemiological research; and a “consent for contact” method to support patients to choose whether they want to participate in face-to-face research. The software was developed in the University of Cambridge and has been peer-reviewed. Amongst other projects, it creates the CPFT Research Database (https://www.cpft.nhs.uk/research-database/).

The Cambridge Cognitive and Psychiatric Assessment Kit (CamCOPS)

This free open-source software enables patients, research subjects, clinicians, and researchers to record information relevant to neuropsychiatry, such as questionnaires about mood or animated tests of brain function. It was and continues to be developed at the University of Cambridge, has been peer-reviewed and subject to security testing, and is in use in the UK and elsewhere. It has roles in clinical practice as well as research. Data can be captured on mobile devices, such as a patient’s phone or tablet, and is sent securely to a server managed by the hosting organisation (such as an NHS Trust or a university research department). 

Medicines Discovery Catapult (MDC)

As part of DATAMIND’s business development and sustainability core activities, connections were established between DATAMIND and Medicines Discovery Catapult (MDC), including participation in their 6-monthly industrial forum. During discussions, the possibility of using genomic datasets collected as part of pharma sponsored clinical trials was proposed as a means of better understanding how antidepressants work and why they work better for some people more than others. The discussions led to the involvement of MDC and pharma partners, including J&J, who have recently made some of their data available for meta-analysis. The discussion culminated in the development of an application to Wellcome’s mental health call “Looking backwards, moving forwards” entitled “Understanding the causal mechanisms of antidepressant exposure and response” that sought to identify unpublished pharma datasets that were collected as part of a clinical trial or observational study of antidepressants. The grant was subsequently awarded, representing an investment of £4.29M in the field of mental health, strengthening links between DATAMIND, MDC and the Pharmaceutical Industry.

The MHG Observatory

The DATAMIND-Observatory is led by Dr Matthias Pierce and is a newly established research unit hosted by the University of Manchester, delivered as a core component of DATAMIND. The Observatory forms part of DATAMIND’s national “single front door” for engagement with mental health data and analytics, working alongside the DATAMIND Trusted Research Environment (TRE) to reduce barriers to access, improve transparency, and accelerate responsible research and innovation.

While DATAMIND provides the secure, scalable infrastructure and governance for mental health data, the Observatory translates these resources into actionable insights, particularly for industry, policy, and therapy development.Hosted in Manchester and working in close partnership with Swansea University and DATAMIND’s wider network, the Observatory will provide a concierge-style analytic service to industry partners, supporting the planning, feasibility, and delivery of mental-health trials in the UK.

It leverages DATAMIND-enabled access to the UK’s unique, high-quality electronic healthcare records and deeply phenotyped mental health cohorts, helping partners understand populations, outcomes, and pathways to impact.This programme of work will be delivered by a multidisciplinary team of health data scientists, AI specialists, and psychiatrists, embedded within DATAMIND’s national infrastructure and adhering to shared standards for security, governance, and FAIR data principles.

All activity will be undertaken with patient and public involvement and engagement (PPIE) at its core, ensuring that analytic outputs are grounded in lived experience, aligned with patient-relevant outcomes, and contribute to public trust in the use of mental health data. Through this collaboration, the DATAMIND-Manchester Observatory plays a key role in demonstrating responsible, large-scale use of mental health data, generating strategic insight across the life-course of therapy development and strengthening the UK’s position as a global leader in mental health research and innovation.

Skip to content